MWVC
AGIO icon

Morgens Waterfall Vintiadis & Co’s Agios Pharmaceuticals AGIO Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-21,000
Closed -$1M – 32
2019
Q4 		$1M Buy
+21,000
New +$794K 0.68% 36
2019
Q2 		– Sell
-14,000
Closed -$944K – 58
2019
Q1 		$944K Buy
+14,000
New +$815K 0.68% 38

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's AGIO Position: Q1 2020 in Review

Morgens Waterfall Vintiadis & Co sold out of Agios Pharmaceuticals (AGIO) in Q1 2020, closing a stake of 21,000 shares — an estimated $1M sold.

Morgens Waterfall Vintiadis & Co first reported a position in AGIO in Q1 2019 and held it in 2 quarters. The position peaked at $1M in Q4 2019. 197 funds tracked by Wall St. Rank hold AGIO as of Q1 2020.

  • Morgens Waterfall Vintiadis & Co reported no remaining Agios Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 21,000 Agios Pharmaceuticals shares in Q1 2020, an estimated $1M.
  • Morgens Waterfall Vintiadis & Co first reported a position in Agios Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Morgens Waterfall Vintiadis & Co's Agios Pharmaceuticals position peaked at $1M in Q4 2019.
  • 197 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2020.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q1 2020, filed 15 May 2020.